NCT02988531View on ClinicalTrials.gov

Validation of PET-MRI for Cardiovascular Disease

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 9, 2017

Primary Completion Date

December 7, 2017

Study Completion Date

December 7, 2017

Conditions
MRIPET ScanPositron-Emission TomographyCardiovascular DiseaseCoronary Artery DiseaseMagnetic Resonance Imaging
Interventions
OTHER

PET/MR scan

Patients to undergo PET/MR scanning after PET/CT scan. Patients will have had an injection of 18F Sodium Fluoride for their PET/CT therefore will not need another dose of radiotracer prior to their PET/MR scan.

Trial Locations (1)

EH16 4SB

University of Edinburgh, Edinburgh

All Listed Sponsors
collaborator

British Heart Foundation

OTHER

lead

University of Edinburgh

OTHER

NCT02988531 - Validation of PET-MRI for Cardiovascular Disease | Biotech Hunter | Biotech Hunter